Manipulation of metabolic pathways to promote stem-like and memory T cell phenotypes for immunotherapy
Utilizing the immune system’s capacity to recognize and kill tumor cells has revolutionized cancer therapy in recent decades. Phenotypic study of antitumor T cells supports the principle that superior tumor control is achieved by cells with more long-lived memory or stem-like properties as compared...
Main Author: | Michael D. Claiborne |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1061411/full |
Similar Items
-
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
by: Peter G. Hendrickson, et al.
Published: (2020-01-01) -
The application of natural killer (NK) cell immunotherapy for the treatment of cancer
by: Rayne H Rouce, et al.
Published: (2015-11-01) -
CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies
by: Gamze Gulden, et al.
Published: (2023-01-01) -
Differentiation of Memory CD8 T Cells Unravel Gene Expression Pattern Common to Effector and Memory Precursors
by: Vanessa Neitzke-Montinelli, et al.
Published: (2022-05-01) -
Targeting the hypoxic tumour phenotype with T-cell immunotherapy
by: Chong, T
Published: (2004)